Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers, AbbVie granted breakthrough therapy designation for elotuzumab
Bristol-Myers, AbbVie granted breakthrough therapy designation for elotuzumab
Bristol-Myers, AbbVie granted breakthrough therapy designation for elotuzumab
Submitted by
admin
on May 19, 2014 - 9:17am
Source:
The Fly on the Wall
News Tags:
Bristol-Myers Squibb
AbbVie
elotuzumab
Multiple Myeloma
Headline:
Bristol-Myers, AbbVie granted breakthrough therapy designation for elotuzumab
Do Not Allow Advertisers to Use My Personal information
